{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:31:55Z","timestamp":1785367915840,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Healthcare Research Health Technology Assessment Programme","award":["10\/137\/01"],"award-info":[{"award-number":["10\/137\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2652-1","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T12:04:33Z","timestamp":1526990673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["TISU: Extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"name":"for the TISU Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"McClinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"N\u2019Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Anson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Terry","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"2652_CR1","unstructured":"Menon M, Parulkar BG, Drach GW. Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC, Retnik AB, Vaughan ED, Wein AJ, editors. Campbell's Urology. 7th ed. Philadelphia: WB Saunders Company; 1998. p. 2659\u20132752."},{"key":"2652_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(01)05782-8","volume":"358","author":"G Bihl","year":"2001","unstructured":"Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001;358:651\u20136.","journal-title":"Lancet"},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1258\/0004563011900623","volume":"38","author":"H Wilkinson","year":"2001","unstructured":"Wilkinson H. Clinical investigation and management of patients with renal stones. Ann Clin Biochem. 2001;38:3\u20137.","journal-title":"Ann Clin Biochem"},{"key":"2652_CR4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","volume":"63","author":"KK Stamatelou","year":"2003","unstructured":"Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817\u201323.","journal-title":"Kidney Int"},{"key":"2652_CR5","unstructured":"Hospital Episode Statistics, Admitted Patient Care - England, 2011\u201312: Primary Diagnosis 3 characters table. NHS 2012. \n                    https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-admitted-patient-care-activity\/hospital-episode-statistics-admitted-patient-care-england-2011-12\n                    \n                  . Accessed Nov 2016."},{"key":"2652_CR6","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.eururo.2007.09.039","volume":"52","author":"GM Preminger","year":"2007","unstructured":"Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck AC, Gallucci M, et al. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007;52:1610\u201331.","journal-title":"Eur Urol"},{"key":"2652_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1089\/end.2009.0683","volume":"24","author":"GS Gerber","year":"2010","unstructured":"Gerber GS, Acharya SS. Management of ureteral calculi. J Endourol. 2010;24:953\u20134.","journal-title":"J Endourol"},{"key":"2652_CR8","first-page":"CD006029","volume":"2","author":"G Nabi","year":"2009","unstructured":"Nabi G, Downey P, Keeley FX, Watson GM, McClinton S. Extra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2009;2:CD006029.","journal-title":"Cochrane Database Syst Rev"},{"key":"2652_CR9","doi-asserted-by":"publisher","first-page":"CD006029","DOI":"10.1002\/14651858.CD006029.pub4","volume":"5","author":"OM Aboumarzouk","year":"2012","unstructured":"Aboumarzouk OM, Kata SG, Keeley FX, McClinton S, Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012;5:CD006029. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006029.pub4\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"key":"2652_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978;37:378\u201381.","journal-title":"Ann Rheum Dis"},{"key":"2652_CR11","volume-title":"UK population norms for EQ-5D. Discussion Paper 172","author":"P Kind","year":"1999","unstructured":"Kind P, Hardman G, Macran S. UK population norms for EQ-5D. Discussion Paper 172. York: University of York: Centre for Health Economics; 1999."},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe K, Zwarenstein M. The PRECIS-2 tool: Designing trials that are fit for purpose. BMJ. 2015;350:h2147.","journal-title":"BMJ"},{"key":"2652_CR13","first-page":"MR000032","volume":"12","author":"VC Brueton","year":"2013","unstructured":"Brueton VC, Tierney J, Stenning S, Harding S, Meredith S, Nazareth I, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2013;12:MR000032.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2652-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:22:30Z","timestamp":1558480950000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2652-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"13 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The North of Scotland Research Ethics Committee 2 has reviewed and approved this study for all the UK centres involved (ref- 13\/NS\/0002). The study has been conducted according to the Principles of Good Practice provided by Research Governance Guidelines. We believe this study does not pose any specific risks to individual participants beyond those of any ureteric stone treatment, nor does it raise any extraordinary ethical issues. Annual progress reports and a final report at the conclusion of the trial will be submitted to North of Scotland REC within the timelines defined in the regulations. Written informed consent was obtained from all participants in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"286"}}